|

Follow-up of Patients With Uveal Melanoma Adapted to the Risk of Relapse (SALOME)

RECRUITINGN/ASponsored by Institut Curie
Actively Recruiting
PhaseN/A
SponsorInstitut Curie
Started2020-07-08
Est. completion2037-07-07
Eligibility
Age18 Years+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT04424719

Summary

Biomarkers search for early diagnosis of liver metastases in patients with uveal melanoma who benefit from a follow-up tailored to their personalized risk of relapse.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

1. Patient aged of 18 years or more.
2. Patient with uveal melanoma with high metastatic relapse risk defined as :

   * T2b/c/d ou ≥ T3,
   * or chromosom 3 or chromosom 8 abnormality by CGH array.
3. Completion of treatment of the primary tumor ≤ 2 months.
4. Patient able to comply with the schedule of visits and blood samples of the study.
5. Signed informed consent form or legal representative.

Exclusion Criteria:

1. Patient without french social insurance.
2. Any social, medical or psychological condition making the research process impossible.

Conditions2

CancerUveal Melanoma

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.